CLINICAL_TRIALS
trial_result
· 2019-03-14
Clinical Trial Update: Oxytocin Suppresses Substance Use Disorders Associated With Chronic Stress [Phase 1]
Summary
Phase 1 clinical trial investigating oxytocin for reducing substance use disorders associated with chronic stress has completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Medical University of South Carolina | Conditions: Alcohol Use Disorders | Phase 1 | Status: COMPLETED | Results posted: 2019-03-14